Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers
Smruthi Vijayaraghavan, Cansu Karakaş, Iman Doostan, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 246

Showing 51-75 of 246 citing articles:

Non-Cell Autonomous Effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy
Tareq Saleh, Liliya Tyutynuk-Massey, Emmanuel K. Cudjoe, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 75
Lysosomal trapping of palbociclib and its functional implications
Susana Llanos, Diego Megı́as, Carmen Blanco‐Aparicio, et al.
Oncogene (2019) Vol. 38, Iss. 20, pp. 3886-3902
Open Access | Times Cited: 70
Autophagy-induced senescence is regulated by p38α signaling
Konstantin Slobodnyuk, Nevenka Radic, Saška Ivanova, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 6
Open Access | Times Cited: 70
Hypoxia-mediated drug resistance in breast cancers
Courtney E. McAleese, Chandra Choudhury, Neville J. Butcher, et al.
Cancer Letters (2020) Vol. 502, pp. 189-199
Closed Access | Times Cited: 67
Dual Inhibition of CDK4 and CDK2 via Targeting p27 Tyrosine Phosphorylation Induces a Potent and Durable Response in Breast Cancer Cells
Priyank Patel, Vladislav Tsiperson, Susan Gottesman, et al.
Molecular Cancer Research (2018) Vol. 16, Iss. 3, pp. 361-377
Open Access | Times Cited: 63
Abemaciclib induces atypical cell death in cancer cells characterized by formation of cytoplasmic vacuoles derived from lysosomes
Hirotsugu Hino, Noriyoshi Iriyama, Hiroko Kokuba, et al.
Cancer Science (2020) Vol. 111, Iss. 6, pp. 2132-2145
Open Access | Times Cited: 63
Mechanisms of CDK4/6 Inhibitor Resistance in Luminal Breast Cancer
Zhen Li, Wei Zou, Ji Zhang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 63
Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition
Anne Fassl, Christopher T. Brain, Monther Abu-Remaileh, et al.
Science Advances (2020) Vol. 6, Iss. 25
Open Access | Times Cited: 60
Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment
Ying Ji, Xiangsheng Liu, Juan Li, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 57
Synergistic anti-cancer activity of CDK4/6 inhibitor palbociclib and dual mTOR kinase inhibitor MLN0128 in pRb-expressing ER-negative breast cancer
Takuro Yamamoto, Noriko Kanaya, George Somlo, et al.
Breast Cancer Research and Treatment (2019) Vol. 174, Iss. 3, pp. 615-625
Open Access | Times Cited: 56
P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy
Diego M. Fernández‐Aroca, O. Roche, S. Sabater, et al.
Cancer Letters (2019) Vol. 451, pp. 23-33
Open Access | Times Cited: 56
CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Perspectives
Michela Roberto, Antonio Astone, Andrea Botticelli, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 332-332
Open Access | Times Cited: 53
CDK4/6 Inhibitors in Melanoma: A Comprehensive Review
Mattia Garutti, Giada Targato, Silvia Buriolla, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1334-1334
Open Access | Times Cited: 53
The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma
Zirong Chen, Wei Ni, Jian‐Liang Li, et al.
JCI Insight (2021) Vol. 6, Iss. 7
Open Access | Times Cited: 52
The Multifaceted Functions of Autophagy in Breast Cancer Development and Treatment
Nicolas J. Niklaus, Igor Tokarchuk, Mara Zbinden, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1447-1447
Open Access | Times Cited: 52
Cyclin D degradation by E3 ligases in cancer progression and treatment
Shuo Qie, J. Alan Diehl
Seminars in Cancer Biology (2020) Vol. 67, pp. 159-170
Open Access | Times Cited: 51
mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership
Ángel Cayo, Raúl Segovia, Whitney Venturini, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8149-8149
Open Access | Times Cited: 47
Potential Prospect of CDK4/6 Inhibitors in Triple-Negative Breast Cancer
Ye Hu, Jiyue Gao, Meiling Wang, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 5223-5237
Open Access | Times Cited: 45
Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
Erin R. Scheidemann, Ayesha N. Shajahan‐Haq
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12292-12292
Open Access | Times Cited: 44
Resistance to CDK4/6 inhibition: Mechanisms and strategies to overcome a therapeutic problem in the treatment of hormone receptor-positive metastatic breast cancer
Marios Papadimitriou, Anastasia Pazaiti, Konstantinos Iliakopoulos, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2022) Vol. 1869, Iss. 12, pp. 119346-119346
Open Access | Times Cited: 35
CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review
Gian Luca Rampioni Vinciguerra, Maura Sonego, Ilenia Segatto, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 30
The BET inhibitor/degrader ARV-825 prolongs the growth arrest response to Fulvestrant + Palbociclib and suppresses proliferative recovery in ER-positive breast cancer
Ryan Finnegan, Ahmed M. Elshazly, Nipa Patel, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 19
Six‐Membered Aromatic Nitrogen Heterocyclic Anti‐Tumor Agents: Synthesis and Applications
Jiatong Li, Ao Gu, Xiao‐Mei Nong, et al.
The Chemical Record (2023) Vol. 23, Iss. 12
Closed Access | Times Cited: 17
Autophagy and senescence facilitate the development of antiestrogen resistance in ER positive breast cancer
Michael K. McGrath, Ali Abolhassani, Luke Guy, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 6
mTORC1/2 inhibitor and curcumin induce apoptosis through lysosomal membrane permeabilization-mediated autophagy
Seung Un Seo, Seon Min Woo, Hyun‐Shik Lee, et al.
Oncogene (2018) Vol. 37, Iss. 38, pp. 5205-5220
Open Access | Times Cited: 50

Scroll to top